Tubeimoside I Inhibits the Growth of Triple-Negative Breast Cancer via the NR3 C2/PI3 K/AKT Signaling Pathway

Scientists used a comprehensive approach involving bioinformatics analysis and in vivo and in vitro experiments to investigate the effects of TBMS1 on triple-negative breast cancer (TNBC) cells and elucidated the underlying molecular mechanisms involved.